NASDAQ:OASM
Delisted
Oasmia Pharmaceutical AB Stock News
$1.42
+0.0050 (+0.353%)
At Close: Feb 07, 2020
Kazia Therapeutics Licenses Cantrixil To Oasmia Pharmaceutical For Ovarian Cancer
08:39am, Monday, 01'st Mar 2021
Kazia Therapeutics Ltd (NASDAQ: KZIA) has entered an exclusive worldwide licensing agreement with Oasmia Pharmaceutical AB (OTCMKTS: OASMY) for Cantrixil under development the treatment of ovari
